No TUEs, No Exceptions Unlike corticosteroids or hormone therapies that may qualify for a Therapeutic Use Exemption (TUE), BPC-157 has no approved medical use , so theres no path to exemption
All of the ingredients used in IVs are manufactured or compounded in FDA-registered facilities under stringent quality control guidelines
Dihexa is a synthetic hexapeptide that binds to the c-Met receptor (hepatocyte growth factor receptor) and amplifies endogenous HGF signaling, potentiating BDNF-TrkB pathway activity by stabilizing receptor-ligand interactions with binding affinity 10,000,000 times greater than natural ligands
Finally, we briefly describe how the GH/IGF-I axis is impacted by liver disease, weight loss, GH misuse for recreational and athletic performance-enhancing, GH-releasing hormone (GHRH) analog use in HIV lipodystrophy, and the alterations of the GH/IGF-I axis in subjects with congenital isolated GH and IGF-I deficiencies